Five Prime Therapeutics Inc (NASDAQ:FPRX)

25.64
Delayed Data
As of Mar 05
 +0.56 / +2.23%
Today’s Change
10.50
Today|||52-Week Range
28.47
-5.04%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 32.00, with a high estimate of 35.00 and a low estimate of 28.00. The median estimate represents a +24.80% increase from the last price of 25.64.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.10
Sales
$12.4M
Reporting Date
Mar 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 70.91%
 
 
 
 
 
 
Growthannually 75.03%
 
 
 

Sales

Growthquarterly 104.77%
 
 
 
 
 
 
Growthannually 95.91%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account